InformasjonHypogonadisme er en sjelden tilstand hos menn som har for lite testosteron i blodet. Illustrasjonsfoto: Colourbox
Mannlig hypogonadisme
Mannlig hypogonadisme skyldes nedsatt produksjon av kjønnshormonet testosteron. Det kan skyldes svikt i reguleringen fra hjernen eller sykdom i selve testiklene.
Sist oppdatert:
14. mars 2022
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Mannlig hypogonadisme . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol. 2008;159:507-514. PubMed
- Svartberg JB, Jørgensen AP, Haave EM, Finnes TE. Mannlig hypogonadisme. Nasjonal veileder i endokrinologi. Publisert 30.09.2021. www.prosedyrer.no
- Tajar A, Forti G, O'Neill TW, et al; EMAS Group. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European male ageing study. J Clin Endocrinol Metab. 2010;95:1810-1818. PubMed
- Corona G, Lee DM, Forti G et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med 2010;7:1362-80. PubMed
- Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363: 123-35. pmid:20554979 PubMed
- Smith HS, Elliot JA. Opioid-induced androgen deficiency (OPIAD). Pain Physician 2012; 15: 145-56. pmid:22786453 PubMed
- Andersen M, Arntsen SA, Eriksen EF, et al. Hypogonadisme. Norsk urologisk forenings anbefalinger for allmennleger 2013.
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med 2016; 374: 611. pmid:26886521 PubMed
- Resnick SM, et al. Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment. JAMA 2017; 317: 708. doi:10.1001/jama.2016.21044 DOI
- Budoff MJ, et al. Testosterone treatment and coronary artery plaque volume in older men with low testosterone. JAMA 2017; 317: 708. doi:10.1001/jama.2016.21043 DOI
- Barbonetti A, D'Andrea S, Francavilla S. Testosterone replacement therapy. Andrology. 2020;8(6):1551-1566. PubMed
- Corona G, Rastrelli G, Morgentaler A, et al. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. Eur Urol 2017. pmid:28434676 PubMed
- Bhasin S, Travison TG, Pencina KM, et al. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023: 6: e2348692. PMID: 38150256 PubMed
- Vigen R, O’Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013; 310: 1829-36 Journal of the American Medical Association
- Caminiti G, Volterrani M, Iellamo F, et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009; 54: 919-27. pmid:19712802 PubMed
- Hudson J, Cruickshank M, Quinton R, et al. Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. Lancet Healthy Longevity 2022; 3: 381-393. doi:10.1016/S2666-7568(22)00096-4 DOI
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med 2023. PMID: 37326322 PubMed
- Walker RF, Zakai NA, MacLehose RF, et al. Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism. JAMA Intern Med 2019. pmid:31710339 PubMed
- Ayele HT, Brunetti VC, Renoux C, et al. Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials. Thromb Res. 2021 Jan 6;199:123-131. PMID: 33486321 PubMed
- Jones TH, Arver S, Behre HM, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 2011; 34: 828-37. pmid:21386088 PubMed
- Diem SJ, Greer NL, MacDonald R, et al. Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med. 2020. PMID: 31905375 PubMed
- Snyder PJ, Bauer DC, Ellenberg SS, et al. Testosterone Treatment and Fractures in Men with Hypogonadism. N Engl J Med 2023; 390: 203-211. pmid:38231621 PubMed
- Tharu T, Saful M, Channa J, Suks M. Investigating the basis of sexual dysfunction during late-onset hypogonadism. F1000Research 2019. doi:10.12688/f1000research.16561.1 DOI